Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension

摘要

The present invention relates to the use of a vector which comprises a nucleic acid encoding an angiogenic factor for preventing, ameliorating or treating pulmonary hypertension. It also relates to specific pharmaceutical compositions which enable these vectors to be administered locally and efficiently.